________________________________________________________________________________________________________________________________
TALEs, Zinc Fingers, or MeganucleasesMoving beyond widely-used radioactive induced mutation breeding and conventional transgenic crop improvement. Johan Botterman, Head of Product Research Bayer CropScience NV shares his professional experience and opinion on novel genome editing technologies. An assessment and perspective from industry practice. Read more ... |
Network intelligence for Lundbeck’s new drugsThe success of its new drugs against alcohol abuse critically depends on the Danish drugmaker's capability to outbeat generics and more distinctive improvements than other branded therapeutics after market launch. Read more ... |
Metrics for Disease, Health, and WellnessPersonalized medicine? A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, Institute for Systems Biology at Seattle. |
Chemical Industry leaders get to the heart
Sustainability refers to more than “green” or “bio-based”
What value does green chemistry really have for construction? Will this industry sector benefit from “bio-based economy” How and where in the world is product cost important for innovators? What is the role of biotechnology for innovating Italy’s economy in total? Giorgio Squinzi, President of Mapei SpA and of Italian manufacturers’ industry association Confindustria shares his opionion with some fresh ideas on sustainability.
Read more ...
Resolving the Innovation Paradox
Resolving the Innovation paradox with examples from power storage, catalysts, and bringing 2nd generation into the global market without tax payers' subsidies. In the exclusive interview with B2Bioworld Günter von Au, Designated Board Member of Clariant and CEO of Süd-Chemie explains what is at stake and talks about his personal plans once resigning his chairmanship.
Read more ...
UK Chemical Industries Lessons From the Recession
The chemicals industry in the UK his coming out of some quite difficult times. How sustainable is recovery? In the exclusive interview with B2Bioworld Dr John Saul, President of CIA provides an outlook on the future of the UK chemicals industry leveraging British Pound, US Dollar and Euro, while seeking opportunities within the UK, in the EU, and emerging countries. Demanding tasks lie ahead.
Read more ...
Corporate announcements
- Biotechnica 2013: Focus on bio-economics
- Global Bioenergies: Financial Results 2012
- Phytowelt ranks among the finalists for the German Economy Prize for Innovation thanks to Eppendorf technology
Products & Services
- Hamamatsu introduces the new ImagEM X2 EM-CCD camera with fast 70 frames per second readout
- STEMCELL Technologies: ALDEFLUOR® Stem Cell Identification & Isolatio